Trial Information
Value of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography and Molecular Tumor Characterisation in Preoperative Staging og Postoperative Control of Colon Cancer
Inclusion Criteria:
- clinical or histological diagnosis of malignant clonic neoplasm (distance of more
than 15 cm from anal ring)
- 18 years of age or older
- written informed consent
Exclusion Criteria:
- diabetes
- known malignant disease other than colon cancer
- known metastatic disease
- impairment of renal function
- allergy to CT contrast agents
- body weight of more than 150 kg
- claustrophobia
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
time to recurrence
Principal Investigator
Bodil E Engelmann, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Naestved Hospital
Authority:
Denmark: The Danish National Committee on Biomedical Research Ethics
Study ID:
SJ-82
NCT ID:
NCT01636674
Start Date:
July 2009
Completion Date:
March 2013
Related Keywords:
- Colon Cancer
- positron emission tomography
- computed tomography
- fluordeoxyglucose
- colon cancer
- cancer
- staging
- imaging
- Colonic Neoplasms